GlaxoSmithKline Czech Republic - Receivables

Created with Highcharts 6.0.4CZK mil2003200420052006200720082009201020112012201320142015201620170250500750100012501500

GlaxoSmithKline CR`s Receivables reached 579 CZK mil in 2017. This is 7.38 % less than in the previous year.

$1.99

Buy Receivables data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic CZK mil
Bayer Czech Republic CZK mil
GlaxoSmithKline Czech Republic CZK mil
Merck Czech Republic CZK mil
Novartis Czech Republic CZK mil
Pfizer Czech Republic CZK mil
Roche Czech Republic CZK mil
Sanofi-Aventis Czech Republic CZK mil
Servier Czech Republic CZK mil
Walmark CZK mil
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...             99.5 112 48.4 137 81.9    
... ... ...                 264 268 356 357 403    
... ... ...                 1,114 1,025 918 659 663    
... ...                   213 252 266 204 210    
                      590 757 1,459 743 799    
... ...                   1,305 900 973 733 1,007    
... ... ...                 983 1,087 1,108 1,101 1,046   ...
... ... ... ...               1,573 1,506 1,293 1,112 1,302    
... ... ... ... ... ... ... ... ... ... ... ... 56.5 48.4 78.4 87.0    
... ... ...                 598 553 516 539 154